V10a91-Tasheva Pgmkr

Total Page:16

File Type:pdf, Size:1020Kb

V10a91-Tasheva Pgmkr Molecular Vision 2004; 10:758-772 <http://www.molvis.org/molvis/v10/a91> ©2004 Molecular Vision Received 12 August 2004 | Accepted 7 October 2004 | Published 7 October 2004 Analysis of transcriptional regulation of the small leucine rich proteoglycans Elena S. Tasheva,1 Bernward Klocke,2 Gary W. Conrad1 1Kansas State University, Division of Biology, Manhattan, KS; 2Genomatix Software GmbH, München, Germany Purpose: Small leucine rich proteoglycans (SLRPs) constitute a family of secreted proteoglycans that are important for collagen fibrillogenesis, cellular growth, differentiation, and migration. Ten of the 13 known members of the SLRP gene family are arranged in tandem clusters on human chromosomes 1, 9, and 12. Their syntenic equivalents are on mouse chromosomes 1, 13, and 10, and rat chromosomes 13, 17, and 7. The purpose of this study was to determine whether there is evidence for control elements, which could regulate the expression of these clusters coordinately. Methods: Promoters were identified using a comparative genomics approach and Genomatix software tools. For each gene a set of human, mouse, and rat orthologous promoters was extracted from genomic sequences. Transcription factor (TF) binding site analysis combined with a literature search was performed using MatInspector and Genomatix’ BiblioSphere. Inspection for the presence of interspecies conserved scaffold/matrix attachment regions (S/MARs) was performed using ElDorado annotation lists. DNAseI hypersensitivity assay, chromatin immunoprecipitation (ChIP), and transient transfection experiments were used to validate the results from bioinformatics analysis. Results: Transcription factor binding site analysis combined with a literature search revealed co-citations between several SLRPs and TFs Runx2 and IRF1, indicating that these TFs have potential roles in transcriptional regulation of the SLRP family members. We therefore inspected all of the SLRP promoter sets for matches to IRF factors and Runx factors. Positionally conserved binding sites for the Runt domain TFs were detected in the proximal promoters of chondroadherin (CHAD) and osteomodulin (OMD) genes. Two significant models (two or more transcription factor binding sites ar- ranged in a defined order and orientation within a defined distance range) were derived from these initial promoter sets, the HOX-Runx (homeodomain-Runt domain), and the ETS-FKHD-STAT (erythroblast transformation specific-forkhead- signal transducers and activators of transcription) models. These models were used to scan the genomic sequences of all 13 SLRP genes. The HOX-Runx model was found within the proximal promoter, exon 1, or intron 1 sequences of 11 of the 13 SLRP genes. The ETS-FKHD-STAT model was found in only 5 of these genes. Transient transfections of MG-63 cells and bovine corneal keratocytes with Runx2 isoforms confirmed the relevance of these TFs to expression of several SLRP genes. Distribution of the HOX-Runx and ETS-FKHD-STAT models within 200 kb of genomic sequence on human chromosome 9 and 500 kb sequence on chromosome 12 also were analyzed. Two regions with 3 HOX-Runx matches within a 1,000 bp window were identified on human chromosome 9; one located between OMD and osteoglycin (OGN)/ mimecan genes, and the second located upstream of the putative extracellular matrix protein 2 (ECM2) promoter. The intergenic region between OMD and mimecan was shown to coincide with different patterns of DNAse I hypersensitivity sites in MG-63 and U937 cells. ChiP analysis revealed that this region binds Runx2 in U937 cells (mimecan transcript note detectable), but binds Pitx3 in MG-63 cells (expressing high level of mimecan), thereby demonstrating its functional association with mimecan expression. Upon comparing the predictions of S/MARs on the relevant chromosomal context of human chromosomes 9 and 12 and their rodent equivalents, no convincing evidence was found that the tandemly arranged genes build a chromosomal loop. Conclusions: Twelve of 13 known SLRP genes have at least one HOX-Runx module match in their promoter, exon 1, intron 1, or intergenic region. Although these genes are located in different clusters on different chromosomes, the com- mon HOX-Runx module could be the basis for co-regulated expression. The process of transcription is the key element in gene nals for transcription factors and that promoters bear the his- expression and, as such, an attractive control point for regula- tone code: H3 hyperacetylation and methylation of lysine 4 tion of gene expression in cell and tissue specific manners. It [1]. Various models demonstrate how the two types of com- is not surprising that considerable research has been conducted plexes, the nucleosome remodeling complexes of the SWI/ on elucidating the mechanisms by which genes are regulated SNF (switch/sucrose non-fermentable) type, which use the [1-7]. Current views of transcriptional regulation incorporate energy of ATP-hydrolysis to alter histone-DNA contacts, and the histone code hypothesis which proposes that different com- the enzymatic complexes that modify histones by acetylation, binations of histone modifications function as recognition sig- methylation, phosphorylation, and ubiquitinylation participate in chromatin remodeling [1-7]. Models also explain how regu- Correspondence to: Elena S. Tasheva, Division of Biology, Ackert latory motifs act at a distance and involve looping to bring Hall, Kansas State University, Manhattan, KS, 66506-4901; Phone: regulatory elements in contact with distant promoters. Regu- (785) 532-6553; FAX: (785) 532-6653; email: [email protected] latory motifs are seen as binding sites for proteins that induce 758 Molecular Vision 2004; 10:758-772 <http://www.molvis.org/molvis/v10/a91> ©2004 Molecular Vision chemical modifications and structural alterations propagating ture and that regulatory effects of a control region depend on down the fiber [5]. In addition to studying regulation of tran- the specific combination of elements, as well as the order and scription through a variety of biological and biochemical ap- orientation in which they occur [8,10,16]. The ability of a given proaches, recently there has been much interest in the possi- sequence-specific transcription factor to interact with both co- bility of using bioinformatics approaches to identify gene regu- activators and co-repressors and/or to recruit histone-modify- latory elements [8-10]. Large scale cross-species DNA se- ing proteins is thought to provide a simple means for generat- quence comparisons reveal regions of highly conserved non- ing on-off switches in a tissue specific manner during the cell- coding sequences located upstream of transcription initiation cycle, and in development [1-4,7]. In addition to the order and sites (gene promoters), or in introns and intergenic regions orientation of units of transcription regulatory regions, the (enhancers, silencers, scaffold/matrix attachment region (S/ abundance of transcriptional cofactors in a certain cell type MARs), and locus control regions) [11-15]. Functional analy- also influences the ability of site specific factors to regulate ses of these conserved regions show that they represent cis- gene expression [17]. Thus, a combination of bioinformatics regulatory elements that control expression of nearby genes. and wet lab experiments has emerged as a successful method Data indicate that these regulatory regions have modular struc- for detecting cis-regulatory elements in many genomic loci, including those for homeodomain containing transcription factors (HOX), immunoglobulin, β-globin, and IL4/IL13/IL5- cytokine gene clusters [18-21]. The small lecine rich proteoglycans (SLRPs) are a well- known family of secreted proteoglycans present in many con- nective tissues. Crucial roles of these macromolecules in ma- trix assembly and modulation of cellular growth have been demonstrated extensively in the literature [22-25]. In the eye, SLRPs have been shown to be equally important for develop- ment and maintenance of corneal transparency and for pro- viding the structural link between the neural retina and retinal pigment epithelium [26,27]. Alterations in the balance of cor- neal SLPGs result in increased hydration and loss of corneal transparency. In vitro data demonstrate that these molecules regulate axon guidance and synapse formation during the de- velopment of nervous tissue and the vertebrate retina. Indi- vidual roles of several SLRPs have been demonstrated by pro- duction of gene knock-out animals. All single or double SLRP- null mice generated so far displayed abnormal collagen fibrillogenesis and developed a variety of diseases such as osteoporosis, osteoarthritis, muscular dystrophy, Ehlers-Danlos syndrome, and corneal pathology, e.g. diseases that appear to result from collagen defects [28-33]. Phenotypic changes in different SLRP-null mice are mild, indicating that these pro- teins can compensate for one another, as evidenced by an in- creased amount of lumican in fibromodulin-null mice [31]. Although the molecular bases for these compensatory mecha- nisms presently are unknown, it is likely that this might occur at the level of transcription. The notion of regulated expres- sion of the SLRPs at the level of transcription is supported by their genomic organization. Thus, 10 of the 13 members of the SLRP gene family are organized in clusters on three chro- mosomes: opticin (OPTC), proline arginine rich end leucine rich repeat protein (PRELP), and fibromodulin (FMOD) on human chromosome 1q3 (their
Recommended publications
  • PLZF Targets Developmental Enhancers for Activation During Osteogenic Differentiation of Human Mesenchymal Stem Cells
    RESEARCH ARTICLE PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells Shuchi Agrawal Singh1,2,3*, Mads Lerdrup1,3, Ana-Luisa R Gomes1,3, Harmen JG van de Werken4,5,6, Jens Vilstrup Johansen1,3,7, Robin Andersson1,3,7, Albin Sandelin1,3,7, Kristian Helin8,9,10, Klaus Hansen1,3* 1Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 2Department of Hematology, Cambridge Institute for Medical Research and Welcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom; 3Centre for Epigenetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 4Department of Cell Biology, University Medical Center, Rotterdam, Netherlands; 5Cancer Computational Biology Center, University Medical Center, Rotterdam, Netherlands; 6Department of Urology, University Medical Center, Rotterdam, Netherlands; 7Department of Biology, The Bioinformatics Centre, University of Copenhagen, Copenhagen, Denmark; 8The Novo Nordisk Center for Stem Cell Biology, Faculty of Health and Medical Sciences University of Copenhagen, Copenhagen, Denmark; 9Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States; 10Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, United States *For correspondence: [email protected]; Abstract The PLZF transcription factor is essential for osteogenic differentiation of hMSCs; [email protected] (SAS); however, its regulation and molecular function during this process is not fully understood. Here, we [email protected] (KHA) revealed that the ZBTB16 locus encoding PLZF, is repressed by Polycomb (PcG) and H3K27me3 in Competing interests: The naive hMSCs. At the pre-osteoblast stage of differentiation, the locus lost PcG binding and authors declare that no H3K27me3, gained JMJD3 recruitment, and H3K27ac resulting in high expression of PLZF.
    [Show full text]
  • A Molecular and Genetic Analysis of Otosclerosis
    A molecular and genetic analysis of otosclerosis Joanna Lauren Ziff Submitted for the degree of PhD University College London January 2014 1 Declaration I, Joanna Ziff, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. Where work has been conducted by other members of our laboratory, this has been indicated by an appropriate reference. 2 Abstract Otosclerosis is a common form of conductive hearing loss. It is characterised by abnormal bone remodelling within the otic capsule, leading to formation of sclerotic lesions of the temporal bone. Encroachment of these lesions on to the footplate of the stapes in the middle ear leads to stapes fixation and subsequent conductive hearing loss. The hereditary nature of otosclerosis has long been recognised due to its recurrence within families, but its genetic aetiology is yet to be characterised. Although many familial linkage studies and candidate gene association studies to investigate the genetic nature of otosclerosis have been performed in recent years, progress in identifying disease causing genes has been slow. This is largely due to the highly heterogeneous nature of this condition. The research presented in this thesis examines the molecular and genetic basis of otosclerosis using two next generation sequencing technologies; RNA-sequencing and Whole Exome Sequencing. RNA–sequencing has provided human stapes transcriptomes for healthy and diseased stapes, and in combination with pathway analysis has helped identify genes and molecular processes dysregulated in otosclerotic tissue. Whole Exome Sequencing has been employed to investigate rare variants that segregate with otosclerosis in affected families, and has been followed by a variant filtering strategy, which has prioritised genes found to be dysregulated during RNA-sequencing.
    [Show full text]
  • A Single-Cell Transcriptomic Landscape of Primate Arterial Aging
    ARTICLE https://doi.org/10.1038/s41467-020-15997-0 OPEN A single-cell transcriptomic landscape of primate arterial aging Weiqi Zhang 1,2,3,4,5,13, Shu Zhang6,7,13, Pengze Yan3,8,13, Jie Ren7,9,13, Moshi Song3,5,8, Jingyi Li2,3,8, Jinghui Lei4, Huize Pan2,3, Si Wang3,5,8, Xibo Ma3,10, Shuai Ma2,3,8, Hongyu Li2,3, Fei Sun2,3, Haifeng Wan3,5,11, ✉ ✉ ✉ Wei Li 3,5,11, Piu Chan4, Qi Zhou3,5,11, Guang-Hui Liu 2,3,4,5,8 , Fuchou Tang 6,7,9,12 & Jing Qu 3,5,11 Our understanding of how aging affects the cellular and molecular components of the vas- 1234567890():,; culature and contributes to cardiovascular diseases is still limited. Here we report a single-cell transcriptomic survey of aortas and coronary arteries in young and old cynomolgus monkeys. Our data define the molecular signatures of specialized arteries and identify eight markers discriminating aortic and coronary vasculatures. Gene network analyses characterize tran- scriptional landmarks that regulate vascular senility and position FOXO3A, a longevity- associated transcription factor, as a master regulator gene that is downregulated in six subtypes of monkey vascular cells during aging. Targeted inactivation of FOXO3A in human vascular endothelial cells recapitulates the major phenotypic defects observed in aged monkey arteries, verifying FOXO3A loss as a key driver for arterial endothelial aging. Our study provides a critical resource for understanding the principles underlying primate arterial aging and contributes important clues to future treatment of age-associated vascular disorders. 1 CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Microarray Analysis of Bone Marrow Lesions in Osteoarthritis
    ARD Online First, published on July 13, 2017 as 10.1136/annrheumdis-2017-211396 Basic and translational research Ann Rheum Dis: first published as 10.1136/annrheumdis-2017-211396 on 13 July 2017. Downloaded from EXTENDED REPORT Microarray analysis of bone marrow lesions in osteoarthritis demonstrates upregulation of genes implicated in osteochondral turnover, neurogenesis and inflammation Anasuya Kuttapitiya,1 Lena Assi,1 Ken Laing,1 Caroline Hing,2 Philip Mitchell,2 Guy Whitley,3 Abiola Harrison,1 Franklyn A Howe,3 Vivian Ejindu,2 Christine Heron,2 Nidhi Sofat1 ► Additional material is ABSTRACT affecting the knees in up to 37% of adults over published online only. To view Objective Bone marrow lesions (BMLs) are well 60.1 Pain is a major symptom for people with OA, please visit the journal online described in osteoarthritis (OA) using MRI and are with 16.7% of US adults aged 45 years and above (http:// dx. doi. org/ 10. 1136/ 1 annrheumdis- 2017- 211396). associated with pain, but little is known about their reporting pain as a predominant problem. pathological characteristics and gene expression. We Pain in OA is thought to arise from several 1 Institute for Infection & evaluated BMLs using novel tissue analysis tools to gain structures within the arthritic joint, including the Immunity, St George's, a deeper understanding of their cellular and molecular synovium (from which prostaglandins, leukot- University of London, London, UK expression. rienes and inflammatory mediators are released), 2St George's University Methods We recruited 98 participants, 72 with joint effusions, joint capsule involvement, tendon Hospitals NHS Foundation Trust, advanced OA requiring total knee replacement (TKR), 12 and muscle weakness that all contribute to pain London, UK 3 3 with mild OA and 14 non-OA controls.
    [Show full text]
  • Page 1 of 76 Diabetes Diabetes Publish Ahead of Print, Published Online September 14, 2020
    Page 1 of 76 Diabetes Peters, Annette; Helmholtz Center Munich German Research Center for Environmental Health, Epidemiology Institute Waldenberger, Melanie; Helmholtz Center Munich German Research Center for Environmental Health, Molecular Epidemiology Diabetes Publish Ahead of Print, published online September 14, 2020 Diabetes Page 2 of 76 Deciphering the Plasma Proteome of Type 2 Diabetes Mohamed A. Elhadad1,2,3 MSc., Christian Jonasson4,5 PhD, Cornelia Huth2,6 PhD, Rory Wilson1,2 MSc, Christian Gieger1,2,6 PhD, Pamela Matias1,2,3 MSc, Harald Grallert1,2,6 PhD, Johannes Graumann7,8 PhD, Valerie Gailus-Durner9 PhD, Wolfgang Rathmann6,10 MD, Christine von Toerne11 PhD, Stefanie M. Hauck11 PhD, Wolfgang Koenig3,12,13 MD, FRCP, FESC, FACC, FAHA, Moritz F. Sinner3,14 MD, MPH, Tudor I Oprea15,16,17 MD, PhD, Karsten Suhre18 PhD, Barbara Thorand2,6 PhD, Kristian Hveem4,5 PhD, Annette Peters2,3,6,19 PhD, Melanie Waldenberger1,2,3 PhD 1. Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. 2. Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany 3. German Research Center for Cardiovascular Disease (DZHK), Partner site Munich Heart Alliance, Germany 4. K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health, NTNU - Norwegian University of Science and Technology, Trondheim, Norway 5. HUNT Research Center, Department of Public Health, NTNU - Norwegian University of Science and Technology, Levanger, Norway 6. German Center for Diabetes Research (DZD), München-Neuherberg, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany 7. Biomolecular Mass Spectrometry, Max Planck Institute for Heart and Lung Research, Ludwigstrasse 43, Bad Nauheim 61231, Germany 8.
    [Show full text]
  • A New Synuclein-Transgenic Mouse Model for Early Parkinson's Reveals Molecular Features of Preclinical Disease
    bioRxiv preprint doi: https://doi.org/10.1101/2020.04.04.016642; this version posted April 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. A new synuclein-transgenic mouse model for early Parkinson's reveals molecular features of preclinical disease Diana M Hendrickx1,*,#, Pierre Garcia1,2,#, Amer Ashrafi1, Alessia Sciortino1, Kristopher J Schmit1, Heike Kollmus3, Nathalie Nicot4, Tony Kaoma5, Laurent Vallar6, Manuel Buttini1,*,$, Enrico Glaab1,$ 1 Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg 2 Laboratoire National de Sant´e(LNS), Neuropathology Unit, Dudelange, Luxembourg 3 Department of Infection Genetics, Helmholtz Centre for Infection Research, Braunschweig, Germany 4 Quantitative Biology Unit, Luxembourg Institute of Health, Strassen, Luxembourg 5 Department of Oncology, Luxembourg Institute of Health, Strassen, Luxembourg 6 Genomics Research Unit, Luxembourg Institute of Health, Luxembourg, Luxembourg * [email protected]; [email protected] # equal contributor $ equal contributor Abstract Understanding Parkinson's disease (PD) in particular in its earliest phases is important for diagnosis and treatment. However, human brain samples are collected post-mortem, reflecting mainly end stage disease. Because brain samples of mouse models can be collected at any stage of the disease process, they are useful to investigate PD progression. Here, we compare ventral midbrain transcriptomics profiles from α-synuclein transgenic mice with a progressive, early PD-like striatum neurodegeneration across different ages using pathway, gene set and network analysis methods.
    [Show full text]
  • The Role of Stress Related Proteins in Osteoarthritis
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Ghent University Academic Bibliography Ghent University Faculty of Medicine and Health Science The role of stress related proteins in osteoarthritis Nele Juchtmans Promotor: Prof. Dr. Dirk Elewaut Co-Promotor: Dr. Stijn Lambrecht Thesis submitted in fulfillment of the requirements for the degree of Doctor in Biomedical Sciences 2016 3 4 Table of content 1. Introduction ..................................................................... 9 1.1. Main joint tissue components ................................... 11 1.2. Inside osteoarthritis ................................................... 18 1.3. Role of SLRP in degenerative joint diseases ................ 25 1.4. Role of heat shock proteins in stromal tissue of the joints ................................................................................ 32 1.5 References .................................................................. 50 2. Research objective ......................................................... 69 3. Results ............................................................................ 79 3.1. Distinct dysregulation of the small leucine-rich repeat protein (SLRP) family in osteoarthritic labrum compared to articular cartilage .............................................................. 81 3.2. Downregulation of small heat shock proteins in articular cartilage: a novel protective mechanism against osteoarthritis ............................................................
    [Show full text]
  • The Transcription Factor Osterix (SP7) Regulates Bmp6induced Human Osteoblast Differentiation
    ORIGINAL RESEARCH ARTICLE 2677 JournalJournal ofof Cellular The Transcription Factor Physiology Osterix (SP7) Regulates BMP6-Induced Human Osteoblast Differentiation FENGCHANG ZHU,1 MICHAEL S. FRIEDMAN,1 WEIJUN LUO,2 PETER WOOLF,3 1 AND KURT D. HANKENSON * 1Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 2Department of Biomedical Engineering, School of Engineering, University of Michigan, Ann Arbor, Michigan 3Department of Chemical Engineering, School of Engineering, University of Michigan, Ann Arbor, Michigan The transcription factor Osterix (Sp7) is essential for osteoblastogenesis and bone formation in mice. Genome wide association studies have demonstrated that Osterix is associated with bone mineral density in humans; however, the molecular significance of Osterix in human osteoblast differentiation is poorly described. In this study we have characterized the role of Osterix in human mesenchymal progenitor cell (hMSC) differentiation. We first analyzed temporal microarray data of primary hMSC treated with bone morphogenetic protein-6 (BMP6) using clustering to identify genes that are associated with Osterix expression. Osterix clusters with a set of osteoblast-associated extracellular matrix (ECM) genes, including bone sialoprotein (BSP) and a novel set of proteoglycans, osteomodulin (OMD), osteoglycin, and asporin. Maximum expression of these genes is dependent upon both the concentration and duration of BMP6 exposure. Next we overexpressed and repressed Osterix in primary hMSC using retrovirus. The enforced expression of Osterix had relatively minor effects on osteoblastic gene expression independent of exogenous BMP6. However, in the presence of BMP6, Osterix overexpression enhanced expression of the aforementioned ECM genes. Additionally, Osterix overexpression enhanced BMP6 induced osteoblast mineralization, while inhibiting hMSC proliferation.
    [Show full text]
  • Roles of the Small Leucine-Rich Repeat Proteoglycans OMD and PRELP in Development and Cancer
    UCL-University College London Institute of Ophthalmology Faculty of Brain Sciences Roles of the small leucine-rich repeat proteoglycans OMD and PRELP in development and cancer By Vasiliki Papadaki Thesis submitted to University College London for the degree of Doctor of Philosophy 2014 1 Declaration I, Vasiliki Papadaki confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. Also, the current thesis does not exceed the maximum limit of 100,000 words. 2 Abstract Osteomodulin (OMD) and Proline/arginine-rich and Leucine-rich Repeat protein (PRELP) belong to the small leucine-rich repeat proteoglycan (SLRP) family and as extracellular matrix components have the ability to influence various cellular functions, including cell growth, migration and proliferation, while their mutation or aberrant expression can cause developmental disorders and cancer. This thesis extends previous work in further understanding the roles of OMD and PRELP in cancer and also during mouse development. In the current project OMD and PRELP are overexpressed in a bladder cancer cell line where they are found to alter cell morphology, reduce cell invasion and anchorage-independent growth, while they also inhibit tumour growth in xenograft mouse models. Additionally, we show that OMD and PRELP mediate their effects by cross-regulating different signalling pathways and also by affecting tight junction formation. Furthermore, novel knock-out mouse models of OMD and PRELP were generated, where a Lac-Z cassette has been inserted in the coding regions of the two genes, allowing us to follow their expression under X-gal staining.
    [Show full text]
  • Protein Sequence Comparison of Human and Non-Human Primate
    Protein sequence comparison of human and non-human primate tooth proteomes Carine Froment, Clément Zanolli, Mathilde Hourset, Emmanuelle Mouton-Barbosa, Andreia Moreira, Odile Burlet-Schiltz, Catherine Mollereau To cite this version: Carine Froment, Clément Zanolli, Mathilde Hourset, Emmanuelle Mouton-Barbosa, Andreia Moreira, et al.. Protein sequence comparison of human and non-human primate tooth proteomes. Journal of Proteomics, Elsevier, 2021, 231, pp.104045. 10.1016/j.jprot.2020.104045. hal-03039831 HAL Id: hal-03039831 https://hal.archives-ouvertes.fr/hal-03039831 Submitted on 4 Dec 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Protein sequence comparison of human and non-human primate tooth proteomes Carine Froment1, Clément Zanolli2, Mathilde Hourset3,4, Emmanuelle Mouton-Barbosa1, Andreia Moreira3, Odile Burlet-Schiltz1 and Catherine Mollereau3 1 Institut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, CNRS, UPS, Toulouse, France. 2 Laboratoire PACEA, UMR 5199 CNRS, Université de Bordeaux, Pessac, France.
    [Show full text]
  • Biomolecules
    biomolecules Review From Translation to Protein Degradation as Mechanisms for Regulating Biological Functions: A Review on the SLRP Family in Skeletal Tissues Jérémie Zappia 1 , Marc Joiret 2 , Christelle Sanchez 1,Cécile Lambert 1, Liesbet Geris 2, Marc Muller 3 and Yves Henrotin 1,4,5,* 1 Bone and Cartilage Research Unit, Arthropôle Liège, Center for Interdisciplinary research on Medicines (CIRM) Liège, Liège University, Institute of Pathology, CHU Sart-Tilman, 4000 Liège, Belgium; [email protected] (J.Z.); [email protected] (C.S.); [email protected] (C.L.) 2 Biomechanics Research Unit, B34 GIGA-R, In Silico Medicine, Liège University, CHU Sart-Tilman, 4000 Liège, Belgium; [email protected] (M.J.); [email protected] (L.G.) 3 Laboratory for Organogenesis and Regeneration (LOR), GIGA-Research, Liège University, Avenue de l’Hôpital, B-4000 Liège, Belgium; [email protected] 4 Physical therapy and Rehabilitation department, Princess Paola Hospital, Vivalia, B-6900 Marche-en-Famenne, Belgium 5 Artialis SA, GIGA Tower, Level 3, CHU Sart-Tilman, 4000 Liège, Belgium * Correspondence: [email protected]; Tel.: +32-4-3665937 Received: 2 December 2019; Accepted: 26 December 2019; Published: 3 January 2020 Abstract: The extracellular matrix can trigger cellular responses through its composition and structure. Major extracellular matrix components are the proteoglycans, which are composed of a core protein associated with glycosaminoglycans, among which the small leucine-rich proteoglycans (SLRPs) are the largest family. This review highlights how the codon usage pattern can be used to modulate cellular response and discusses the biological impact of post-translational events on SLRPs, including the substitution of glycosaminoglycan moieties, glycosylation, and degradation.
    [Show full text]